KKR set to hit the jackpot with JB Chemicals and Pharma
The investment giant is rumoured to be eyeing an exit with a 5x return, having taken the drugmaker from obscurity to a billion-dollar bidding war.
30 August, 2024•14 min
0
30 August, 2024•14 min
0
More in Business
Business
Amitabh Chaudhry needs to rethink Axis Mutual Fund’s revival strategy
The fund house has fallen behind its peers. What explains the sub-par performance?
You may also like
Internet
It’s HUMAIN all the way at the desert Davos
Highlights from Saudi Arabia’s flagship FII conference, Tabby’s new valuation and UAE government bonds, among other updates.
Business
Can private equity build the next Max Hospital in Kerala?
Global investors are betting on Kerala’s healthcare boom. But it remains to be seen whether private capital can coexist with the state’s public ethos.
Internet
Gaurav Munjal to finally exit Unacademy
In the making for many months now, the final outcome at the edtech startup is an instructive episode for both founders and venture investors on when they must let go.
